A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Stat: A Case Study In The Fast-Rising Threat Of Antibiotic Resistance In the good old days — way back in early 2012 — people who contracted gonorrhea were given a single pill to cure the infection. A ...

Gepotidacin was non-inferior to ceftriaxone plus azithromycin for the primary outcome of microbiological success. 2. There were no serious or treatment-related adverse events in either group. Evidence ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...

Amid the growing antimicrobial resistance, researchers from IIIT Delhi and a French team have developed an AI-tool to tackle ...

With antibiotic-resistant gonorrhea on the rise, the vaccine could provide a way to prevent the disease from spreading.

According to the World Health Organization, the world is running out of antibiotics to treat certain infections. One infection, in particular, we are seeing a high level of resistance to standard ...

Health authorities in England on Wednesday announced the rollout of a world first vaccine program for gonorrhea, amid record ...